Program Description
Hyperlipidemia is a condition characterized by excessive amounts of lipids in the blood, which can accumulate in plaques that line arterial walls, cause blockages in blood flow to the heart, and ultimately lead to atherosclerotic cardiovascular disease (ASCVD). Cardiovascular disease is the leading cause of death across the globe, and with ASCVD being responsible for a quarter of these deaths, it is imperative that the healthcare team understands all pharmacotherapy options to prevent untimely mortality. Though most patients with hyperlipidemia can be treated with statin therapies, many are intolerant to statins and therefore require non-statin lipid-lowering therapies. Pharmacists must be able to identify high-risk and statin-intolerant patients and intervene with appropriate, non-statin recommendations. This webinar will review the challenges with identification of high-risk patients, application of clinical guidelines, and implementation of strategies to optimize access to non-statin therapies. With a greater understanding of non-statin lipid-lowering treatments, managed care professionals and pharmacists will be better prepared to optimize formulary decisions, improve patient outcomes, and support personalized cardiovascular care.
Target
audience: Managed Care Pharmacist
Type of
activity: Application
Release date: October 30,2025
Expiration date: October 30, 2026
Time to complete activity: 1.0 hours
Learner level: Foundational,
Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine the burden of atherosclerotic cardiovascular disease (ASCVD) and evidence-based approaches to risk stratification and lipid biomarker assessment to identify populations at elevated cardiovascular risk
- Interpret current clinical recommendations using the efficacy and safety of non-statin lipid-lowering therapies
- Prioritize population health strategies in the identification and management of patients with statin intolerance, enabling targeted interventions, optimized access to non-statin therapies, and alignment with value-based care goals
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here